Costa A - Search Results

1

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.

Mulas O, Efficace F, Costa A, Baldi T, Zerbini F, Mantovani D, Morelli E, Perra D, La Nasa G, Caocci G. Mulas O, et al. Among authors: costa a. Ann Hematol. 2024 Jul;103(7):2523-2531. doi: 10.1007/s00277-024-05771-3. Epub 2024 Apr 27. Ann Hematol. 2024. PMID: 38671298 Free PMC article.

2

Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.

Caocci G, Mulas O, Mantovani D, Costa A, Galizia A, Barabino L, Greco M, Murru R, La Nasa G. Caocci G, et al. Among authors: costa a. Ann Hematol. 2022 Apr;101(4):929-931. doi: 10.1007/s00277-021-04613-w. Epub 2021 Jul 24. Ann Hematol. 2022. PMID: 34302519 Free PMC article. No abstract available.

3

Caocci G, Efficace F, Mulas O, Cottone F, Maxia A, Costa A, Simula MP, Usala E, La Nasa G. Caocci G, et al. Among authors: costa a. Ann Hematol. 2022 Apr;101(4):749-754. doi: 10.1007/s00277-021-04750-2. Epub 2022 Jan 31. Ann Hematol. 2022. PMID: 35098366

4

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine.

Galitzia A, Barabino L, Murru R, Caocci G, Greco M, Angioni G, Mulas O, Oppi S, Massidda S, Costa A, La Nasa G. Galitzia A, et al. Among authors: costa a. Vaccines (Basel). 2022 Jul 21;10(7):1162. doi: 10.3390/vaccines10071162. Vaccines (Basel). 2022. PMID: 35891328 Free PMC article.

5

Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy.

Caocci G, Mulas O, Barella S, Orecchia V, Mola B, Costa A, Efficace F, La Nasa G. Caocci G, et al. Among authors: costa a. J Clin Med. 2023 Mar 28;12(7):2547. doi: 10.3390/jcm12072547. J Clin Med. 2023. PMID: 37048630 Free PMC article.

6

Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension.

Mulas O, Mola B, Costa A, Pittau F, Mantovani D, Dessì S, Fronteddu A, La Nasa G, Caocci G. Mulas O, et al. Among authors: costa a. Ann Hematol. 2023 Oct;102(10):2717-2723. doi: 10.1007/s00277-023-05417-w. Epub 2023 Aug 21. Ann Hematol. 2023. PMID: 37603060 Free PMC article.

7

Mulas O, Efficace F, Orofino MG, Piroddi A, Piras E, Vacca A, Barella S, Costa A, Giesinger JM, La Nasa G, Caocci G. Mulas O, et al. Among authors: costa a. J Clin Med. 2023 Sep 19;12(18):6047. doi: 10.3390/jcm12186047. J Clin Med. 2023. PMID: 37762987 Free PMC article.

8

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.

Costa A, Abruzzese E, Latagliata R, Mulas O, Carmosino I, Scalzulli E, Bisegna ML, Ielo C, Martelli M, Caocci G, Breccia M. Costa A, et al. J Clin Med. 2024 Jan 3;13(1):273. doi: 10.3390/jcm13010273. J Clin Med. 2024. PMID: 38202280 Free PMC article.

9

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules.

Bernardi S, Mulas O, Mutti S, Costa A, Russo D, La Nasa G. Bernardi S, et al. Among authors: costa a. Front Oncol. 2024 Jan 8;13:1239042. doi: 10.3389/fonc.2023.1239042. eCollection 2023. Front Oncol. 2024. PMID: 38260856 Free PMC article. Review.

10

Response to Dr. Ying Cui comments.

Mulas O, Efficace F, Costa A, Baldi T, Zerbini F, Mantovani D, Morelli E, Perra D, La Nasa G, Caocci G. Mulas O, et al. Among authors: costa a. Ann Hematol. 2024 Sep;103(9):3829. doi: 10.1007/s00277-024-05914-6. Epub 2024 Jul 30. Ann Hematol. 2024. PMID: 39078436 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,901 results

Search Page

Filters